PITCH DECK – Red Resonance™ Oil
Photoreactive Botanical Therapeutic for Endogenous Light-Driven Healing

PROBLEM
Chronic wounds, inflammatory skin conditions, and slow-healing injuries remain major public health burdens. Conventional therapies often rely on devices, invasive procedures, or steroids—limited by cost, accessibility, and side effects.

SOLUTION
Red Resonance™ Oil is a first-in-class, plant-based topical formulation designed to work with red and near-infrared light already present inside the body to stimulate tissue regeneration, reduce inflammation, and accelerate healing—without requiring external light devices.

TECHNOLOGY

  • Proprietary blend of GRAS botanical extracts (e.g., turmeric, frankincense, ginger) with documented anti-inflammatory and antioxidant effects

  • Photoreactive carrier oils optimized for absorption at 660–850 nm

  • Optional use of plant-derived extracellular vesicles for signal amplification

  • No drug-device classification needed (topical biologic/cosmeceutical model)

MARKET OPPORTUNITY

  • $10B+ market for wound healing, burns, and regenerative skin care

  • Expanding consumer demand for light-based therapy and clean, plant-powered solutions

  • Targeted applications: OTC cosmeceuticals, clinical dermatology, Rx for post-surgical use, global wellness markets

Regulatory & Safety Dossiers

GRAS Status & Dietary Use Review

Conclusion: All ingredients are either GRAS or accepted in food/dietary applications under controlled dosing. St. John’s Wort requires pharmacovigilance labeling. Full ingredient list available upon request for clinicians, regulators, or qualified reviewers. Formula patent-pending.

VALIDATION

  • Patent-pending formulation (USPTO #63/XXXXXX)

  • IRB-ready Phase I pilot study protocol drafted

  • Preclinical lab designs (stability, photoreactivity, in vitro studies)

  • NIH SBIR Phase I proposal drafted for $275K in federal seed funding

BUSINESS MODEL

  • Licensing to wellness & dermaceutical companies

  • B2B clinical distribution to wound care clinics & integrative medicine networks

  • Direct-to-consumer line under FDA monograph or CE mark (EU)

TEAM

  • Now onboarding strategic investors and scientific advisors.

ASK

  • $500K in seed funding for GMP scale-up, IRB trials, and regulatory acceleration

  • Strategic partners in dermatology, medtech, and CPG wellness

CONTACT
Henry Claus
JaraClaus.LLC@gmail.com [816.937.1684]
Jarabrand.com

“Let nature’s light do the healing.”™ – Red Resonance™ Oil